About InVision Medical Technology
InVision Medical Technology is a Y Combinator-backed startup (Summer 2022) that develops artificial intelligence solutions for diagnosing heart disease through automated ultrasound interpretation. The company addresses a critical challenge in cardiology: the 32 million heart ultrasounds performed annually in the United States are time-consuming, requiring over an hour of physician and technician time per exam, and suffer from considerable human-to-human variability that results in misdiagnosis and underdiagnosis. InVision's AI models have been tightly integrated into clinical workflows to enable easy usage by clinicians while improving diagnostic accuracy and efficiency. The company is leading the first and only blinded randomized trial of AI technology in cardiology, with results presented as a Late Breaking Clinical Trial at the European Society of Cardiology. InVision's work has been peer-reviewed and published in top medical venues including Nature (2020), Nature Medicine (2021), Lancet Digital Health (2021), and JAMA Cardiology (2022). The company is currently working on securing FDA clearance for its heart failure model and conducting clinical trials for models screening cardiac amyloidosis, hypertrophic cardiomyopathy, and aortic stenosis. InVision serves hospitals and health systems, with Cedars Sinai Medical Center as the first deployment site.
Mission & Story
Founding Story
Founded by Dr. David Ouyang (cardiologist at Cedars Sinai Medical Center) and Bryan He (PhD Computer Science from Stanford), who worked together on this project for 4 years, first as a research project and now as clinical deployment of a viable product. David completed his MD at UCSF and cardiology fellowship at Stanford, while Bryan completed his CS PhD at Stanford and BS at Caltech.
Clinical Focus
Medical conditions and clinical areas addressed by InVision Medical Technology.
Who It Serves
Milestones & Awards
Recent Milestones
Presented Late Breaking Clinical Trial at European Society of Cardiology. Working on FDA clearance for heart failure model. Starting clinical trials for cardiac amyloidosis, hypertrophic cardiomyopathy, and aortic stenosis screening models. Cedars Sinai Medical Center as first deployment site.
Awards & Recognition
Y Combinator Summer 2022 batch. Presented as headliner clinical trial at European Society of Cardiology conference.
Key Partnerships
Company Details
- Founded
- 2022
- Headquarters
- San Francisco, CA, USA
- Employees
- 1-10
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.